NCT02066714

Brief Summary

Hand Foot and Mouth Disease (HFMD) is a common infectious disease in childhood. Several enteroviruses are associated with the disease. However, since 1997, large outbreaks of HFMD in Taiwan, Malaysia and Vietnam have seen unusual neurological complications such as brainstem encephalitis with rare fatal outcomes. The pathogen associated with this severe disease is Enterovirus 71. In 2011, Vietnam had a large outbreak of Hand Foot and mouth disease resulting in 110,000 cases and 164 deaths. HFMD affects children during their early years of child development, but there is limited information on what the potential long-term consequences are. Small studies have suggested language and cognitive difficulties in more severe disease but this has not been evaluated in a large cohort. Internationally recognized and standardized assessment tools are not available for early childhood in Vietnam. This project will translate and adapt the Bayley Scales of Toddler and Infant Development 3rd edition (Bayley III) and Movement ABC, 2nd edition (MABC) into Vietnamese as outcome measures. This study will evaluate whether there are neurodevelopment difficulties following severe HFMD. The study design is a prospective observational cohort study. Hospitalised children with a clinical diagnosis of HFMD will be eligible to enroll. Written parental consent will be required. Participants enrolled will be assessed 3 times over 18 months from discharge from hospital into the study. Since there is no standardization of Bayley III or MABC for Vietnam, a healthy cohort, age and sex matched to the least severe HFMD participants will be recruited. This healthy cohort will follow the same assessment program over 18 months. A total of 350 HFMD participants and 150 healthy children (matched to the least severe HFMD participants) will be recruited.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
243

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 14, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 19, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

October 4, 2016

Status Verified

October 1, 2016

Enrollment Period

1.5 years

First QC Date

February 14, 2014

Last Update Submit

October 2, 2016

Conditions

Keywords

Enterovirus InfectionsHand, Foot and Mouth DiseaseCoxsackievirus InfectionsHerpanginaCognitionNeurocognitiveSequelaeOutcomes

Outcome Measures

Primary Outcomes (1)

  • Cognitive, language and motor development

    Measured by: Children 36 months and under at enrollment will use the translated and adapted Bayley Scales of Toddler and Infant Development 3rd Edition (Bayley III) for Vietnam. Children 48 months and above at enrollment will use the Vietnamese translation of Movement ABC-2 tool for their assessments. The children aged between 37 and 47 months at enrolment will have both assessments done at both visits.

    18 months post discharge

Secondary Outcomes (1)

  • Neurological status

    18 months post discharge

Other Outcomes (1)

  • Abnormal Brain Image

    During hospital stay (estimate day 10)

Study Arms (2)

Healthy Cohort

These children will be recruited from district 8, Ho Chi Minh City where most HFMD admissions to the Hospital for Tropical Diseases occur. We wil recruit healthy children from three kindergartens and ask for volunteers from participants enrolled in an Oxford University Clinical Research Unit Dengue birth cohort study (OXTREC approval 02-09) in District 8, HCMC. This birth cohort is an observational study.

Hand Foot and Mouth Disease

The Vietnamese Ministry of Health has a clinical grading system. Grade 1 disease is uncomplicated and are not admitted to hospital. Grade 2 and above are admitted to hospital with clinical features of neurological or systemic involvement. Grade 2 is split into Grade 2a and 2b depending if neurological manifestations such as myoclonus have been witnessed by the parents or by a health professional. In total, it is anticipated that 125 Grade 2a and 125 Grade 2b and 100 more severe Grade 3 and 4 will be recruited over one year. A subset who agree for brain magnetic resonance imaging (MRI) will also have a scan done during their hospital admission.

Eligibility Criteria

AgeUp to 4 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Hand foot and mouth disease patients admitted to Hospital of Tropical Diseases. Healthy children form 3 kindergartens in District 8, HCMC and infants enrolled in Dengue Birth cohort (Oxtrec 02-09)

You may qualify if:

  • Hospitalized children ≤ 4 years admitted with HFMD at Hospital for Tropical Diseases (HTD)
  • Parents or legal guardians must give informed consent for their child to participate.

You may not qualify if:

  • Ex-premature children
  • Any prior chronic illness whether required hospitalization or not
  • Previous Pediatric Intensive Care Unit (PICU) admission/ventilation including during neonatal period
  • Prior learning disability or neurological regression
  • Healthy cohort
  • Child age ≤ 4 years
  • Parents or legal guardians must give informed consent for their child to participate.
  • Ex-premature children
  • Any prior chronic illness whether required hospitalization or not
  • Previous PICU admission/ventilation including during neonatal period
  • Prior learning disability or neurological regression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of Tropical Diseases

Ho Chi Minh City, Vietnam

Location

MeSH Terms

Conditions

Hand, Foot and Mouth DiseaseEnterovirus InfectionsCoxsackievirus InfectionsHerpangina

Condition Hierarchy (Ancestors)

Picornaviridae InfectionsRNA Virus InfectionsVirus DiseasesInfectionsEchovirus Infections

Study Officials

  • Saraswathy Sabanathan, MRCPCH

    Oxford University Clinical Reserach Unt, HCMC, Vietnam

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2014

First Posted

February 19, 2014

Study Start

June 1, 2013

Primary Completion

December 1, 2014

Study Completion

August 1, 2016

Last Updated

October 4, 2016

Record last verified: 2016-10

Locations